Thomas Widman - Actelion Ltd Insider

ALIOY -- USA Stock  

USD 70.00  0.00  0.00%


Mr. Thomas Widman is CoFounder at Actelion Ltd. He is a cardiologist educated at Universitat Heidelberg and Paris in Medicine and Computer Science with further training at the University Hospital in Geneva. He later spent seven years at the University of California, San Diego, as Assistant Professor of Medicine and Cardiovascular Associate. During his nine years at F. HoffmannLa Roche, he was responsible for the worldwide clinical development of the company cardiovascular portfolio. He was chairman of F. HoffmannLa Roche cardiovascular strategy team and led an international cardiovascular development team of over 60 people in Europe and the United States. In 1996, he founded Hesperion. Due to his continuing interest in strategic RD and other management topics, he has also attended business courses at INSEAD. As founding member of the Company, he was the Company first Chief Executive Officer and then held the position of Vice Chairman of the Board until spring 2003. He continues to work in close association with the Actelion senior management.
41 61 565 65 65

Management Efficiency

The company has return on total asset (ROA) of 23.87 % which means that it generated profit of $23.87 on every $100 spent on asset. This is very large. Similarly, it shows return on equity (ROE) of 47.08 % meaning that it generated $47.08 on every $100 dollars invested by stockholders.

Entity Summary

Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes low molecular weight drugs for unmet medical needs. The company was founded in 1997 and is headquartered in Allschwil, Switzerland. Actelion Ltd is traded on OTC Market in USA.Actelion Ltd (ALIOY) is traded on OTC Market in USA. It is located in Gewerbestrasse 16 and employs 2,624 people.

Actelion Ltd Leadership Team

Rudi Frank, President, Ph.D
Marian Borovsky, President
Thomas Widman, Founder
Nicholas Franco, President
Christian Albrich, President, MBA
Martine Clozel, President
Robert Bertolini, Director
Juhani Anttila, Director
JeanPierre Garnier, Chairman, MBA
David Stout, Director
JeanPaul Clozel, CEO
Guy Braunstein, President, Ph.D
Herna Verhagen, Director
Andrew Weiss, President, CFA
Michael Jacobi, Director, Ph.D
Jean Malo, Director, MBA
Otto Schwarz, President, Ph.D
Andre Muller, President, MBA
Peter Gruss, Director, Ph.D
John Greisch, Director

Stock Performance Indicators

Current Sentiment - ALIOY

Actelion Ltd Investor Sentiment
Macroaxis portfolio users are unresponsive in their sentiment towards investing in Actelion Ltd. What is your sentiment towards investing in Actelion Ltd? Are you bullish or bearish?
50% Bullish
50% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Actelion Ltd and U S Bancorp. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Commodity Channel Index module to use commodity channel index to analyze current equity momentum.